by Sean Hutchinson | May 31, 2022 | Trademarks
Background In 2021, both Luxembourg’s Tribunal d’arrondissement and Belgium’s Tribunal de l’entreprise francophone de Bruxelles referred cases to the CJEU as Case C-148/21 and Case C 184/21, respectively. These referrals asked the CJEU to decide whether the operator...
by Alex Bajjon | Apr 29, 2022 | EPO
Background Following T 1989/18, many applicants of European patents were of the view that Examining (and Opposition) Divisions could no longer require them to amend the descriptions of their applications prior to grant, so that they conform with the claims. By...
by Eddie Bishop | Apr 25, 2022 | US & International
Questions on the European SPC Regulation, in particular in relation to SPCs for combination products, have been raised at the CJEU many times over the years. It is therefore hoped that this newest referral may provide some much-needed clarity. Background For an SPC to...
by Sean Hughes | Apr 12, 2022 | Briefings, EPO
Overview T 0013/20 concerns the refusal of a patent application with a priority date in July 2004, where the relevant citation is D2: W.E. Ryan: “An Introduction to LDPC Codes”, XP002336953, pp. 1-23. A date of “August 19, 2003” – i.e. before the priority...
by Dr Andrew Clements | Mar 22, 2022 | Briefings, EPO
The EPO has introduced new versions of the Guidelines for Examination in the European Patent Office and the Guidelines for Search and Examination at the EPO as PCT Authority. Both sets of Guidelines took effect on 1 March 2022, as part of the EPO’s regular two-yearly...
by Alex Bajjon | Mar 4, 2022 | UK
Background Neurim previously sued Mylan for infringement in the UK of its European patent no. 1441702, which is related to melatonin for use in improving the sleep quality of a patient suffering from primary insomnia characterised by non-restorative sleep. Mylan...
Recent Comments